The amlexanox group showed marked reduction in ulcer size ( P < 0.001 ) , significant reduction in the visual analog scale scores of pain ( P < 0.001 ) , significant lower scores of erythema and exudation ( P < 0.001 ) when compared to the placebo group on the 6 th day of follow-up .